Current Research on Methamphetamine: Epidemiology, Medical and Psychiatric Effects, Treatment, and Harm Reduction Efforts

Overview

Journal Addict Health

Date 2015 May 19

PMID 25984282

Citations 40

Authors

Seyed Ramin Radfar

Richard A Rawson

Affiliations

Soon will be listed here.

Abstract

Background: Methamphetamine (MA) which is known as "shisheh" in Iran is a drug that widely is used in many parts of the world and it is near to a decade that is available for the most drug users and has a considerable prevalence of use. Due to high abuse prevalence and very new challenging phenomenon, it is very important that researchers and treatment providers become more familiar with different aspects of MA.

Discussion: It has multiple neurobiological impacts on the nervous system, some of which are transitory and some longer lasting. MA activates the reward system of the brain and produces effects that are highly reinforcing, which can lead to abuse and dependence. Routes of administration that produce rapid onset of the drug's effects (i.e., smoking and injection) are likely to lead to more rapid addiction and more medical and psychiatric effects. No effective pharmacotherapies have been developed for the treatment of MA dependence; although, this is an area of very active research. Several behavioral treatments have been shown to reduce MA use, but better treatments are needed.

Conclusion: Harm reduction strategies for non-treatment seeking MA users are needed to reduce the risk of human immunodeficiency virus and other medical risks. The research agenda for MA is substantial, with development of effective pharmacotherapies as one of the most important priorities. Appropriate and effective response for prevention, treatment and harm reduction services due to increasing problems regarding MA in Iran and some other countries in the region.

Citing Articles

Methamphetamine-mediated astrocytic pyroptosis and neuroinflammation involves miR-152-NLRP6 inflammasome signaling axis.

Oladapo A, Kannan M, Deshetty U, Singh S, Buch S, Periyasamy P Redox Biol. 2025; 80:103517.

PMID: 39879739 PMC: 11810843. DOI: 10.1016/j.redox.2025.103517.

A Rare Case of Pneumomediastinum, Pneumoretroperitoneum and Subcutaneous Emphysema Due to Crystal Methamphetamine Abuse.

Abdulmajeed A, Almehrzi M, Al-Bazzaz S, Khalid F, Fathi S, Hefny A Eur J Case Rep Intern Med. 2025; 11(12):005058.

PMID: 39790841 PMC: 11716305. DOI: 10.12890/2024_005058.

Structural Influences on Methamphetamine Use Among Black Sexual Minority Men (HISTORY Study): Protocol for a Longitudinal Cohort Study.

Opara S, Linton S, Weir B, Crawford N, Holland D, Newman Jr A JMIR Res Protoc. 2024; 13:e63761.

PMID: 39481101 PMC: 11565090. DOI: 10.2196/63761.

Ten-year cardiovascular disease risk and related factors in lifetime marijuana use with comorbid methamphetamine-associated psychotic disorder: a QRISK3 study.

Orum D, Orum M, Kapici Y, Abus S BMC Psychiatry. 2024; 24(1):563.

PMID: 39160490 PMC: 11334344. DOI: 10.1186/s12888-024-06018-1.

Modeling methamphetamine use disorder in mammals: Sex differences in behavioral, biochemical, and transcriptional consequences.

Daiwile A, Cadet J Adv Pharmacol. 2024; 99:145-168.

PMID: 38467480 PMC: 11474929. DOI: 10.1016/bs.apha.2023.08.002.

References

RICHARDS C, Clark R, Holbrook T, Hoyt D . The effect of cocaine and amphetamines on vital signs in trauma patients. J Emerg Med. 1995; 13(1):59-63. DOI: 10.1016/0736-4679(94)00123-5. View

Molitor F, Truax S, Ruiz J, Sun R . Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med. 1998; 168(2):93-7. PMC: 1304836. View

Grabowski J, Shearer J, Merrill J, Negus S . Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav. 2004; 29(7):1439-64. DOI: 10.1016/j.addbeh.2004.06.018. View

Reback C, Shoptaw S, Grella C . Methamphetamine use trends among street-recruited gay and bisexual males, from 1999 to 2007. J Urban Health. 2008; 85(6):874-9. PMC: 2587649. DOI: 10.1007/s11524-008-9326-3. View

Harris D, Boxenbaum H, Everhart E, Sequeira G, Mendelson J, Jones R . The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther. 2003; 74(5):475-86. DOI: 10.1016/j.clpt.2003.08.002. View

Rawson R, Shoptaw S, Ling W . Management of methamphetamine abuse and dependence. Curr Psychiatry Rep. 2006; 8(5):345-54. DOI: 10.1007/s11920-006-0035-x. View

Richards J, Bretz S, Johnson E, Turnipseed S, Brofeldt B, Derlet R . Methamphetamine abuse and emergency department utilization. West J Med. 1999; 170(4):198-202. PMC: 1305548. View

Kurtz S . Post-circuit blues: motivations and consequences of crystal meth use among gay men in Miami. AIDS Behav. 2005; 9(1):63-72. DOI: 10.1007/s10461-005-1682-3. View

Cook C, Jeffcoat A . Pyrolytic degradation of heroin, phencyclidine, and cocaine: identification of products and some observations on their metabolism. NIDA Res Monogr. 1990; 99:97-120. View

10.

Hunter C, Strike C, Barnaby L, Busch A, Marshall C, Shepherd S . Reducing widespread pipe sharing and risky sex among crystal methamphetamine smokers in Toronto: do safer smoking kits have a potential role to play?. Harm Reduct J. 2012; 9:9. PMC: 3306827. DOI: 10.1186/1477-7517-9-9. View

11.

Halkitis P, Moeller R, Pollock J . Sexual practices of gay, bisexual, and other nonidentified MSM attending New York City gyms: patterns of serosorting, strategic positioning, and context selection. J Sex Res. 2008; 45(3):253-61. DOI: 10.1080/00224490802204456. View

12.

Shoptaw S, Kao U, Heinzerling K, Ling W . Treatment for amphetamine withdrawal. Cochrane Database Syst Rev. 2009; (2):CD003021. PMC: 7138250. DOI: 10.1002/14651858.CD003021.pub2. View

13.

Wang G, Volkow N, Chang L, Miller E, Sedler M, Hitzemann R . Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry. 2004; 161(2):242-8. DOI: 10.1176/appi.ajp.161.2.242. View

14.

Newton T, Cook I, Kalechstein A, Duran S, Monroy F, Ling W . Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol. 2003; 114(3):410-5. DOI: 10.1016/s1388-2457(02)00409-1. View

15.

Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, Nakatani Y . Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand. 1994; 89(6):428-32. DOI: 10.1111/j.1600-0447.1994.tb01541.x. View

16.

Scott J, Woods S, Matt G, Meyer R, Heaton R, Atkinson J . Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev. 2007; 17(3):275-97. DOI: 10.1007/s11065-007-9031-0. View

17.

Liao M, Jiang Z, Zhang X, Kang D, Bi Z, Liu X . Syphilis and methamphetamine use among female sex workers in Shandong Province, China. Sex Transm Dis. 2010; 38(1):57-62. DOI: 10.1097/OLQ.0b013e3181ebb475. View

18.

Elkashef A, Rawson R, Anderson A, Li S, Holmes T, Smith E . Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology. 2007; 33(5):1162-70. DOI: 10.1038/sj.npp.1301481. View

19.

Volkow N, Wang G, Fowler J, Logan J, Gerasimov M, Maynard L . Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 2001; 21(2):RC121. PMC: 6763805. View

20.

Gizzi M, Gerkin P . Methamphetamine use and criminal behavior. Int J Offender Ther Comp Criminol. 2009; 54(6):915-36. DOI: 10.1177/0306624X09351825. View